Intractable pain

Dec 20, 2019

Saluda Medical Results of U.S. Evoke Pivotal Study through 12 Months Published in The Lancet Neurology

Jun 28, 2019

Saluda Medical Raises $75 Million Equity Financing from Boston Scientific and Redmile Group

Jun 27, 2019

Saluda Medical Secures Debt Financing From Medtronic

May 26, 2019

Nevro to Highlight Substantial Body of Clinical Evidence Supporting Expanded Applications and Unique Capabilities of HF10 Therapy at the 14th International Neuromodulation Society World Congress

May 22, 2018

GB Sciences Will Now Serve A Greatly Expanded Patient Base In Louisiana With The Addition Of Autism, Glaucoma, Parkinson's, PTSD, Intractable Pain And Severe Muscle Spasms To The List Of Ailments Covered By Medical Cannabis Legislation

Apr 26, 2018

New Spinal Stimulation Technology More Effective in Reducing Pain in Patients with Intractable Spine or Limb Pain Compared to Medical Treatment

Apr 11, 2018

Xavant Technology Set to Disrupt Neuropathic Pain Treatment in the UK

Aug 01, 2017

FDA Clears Xavant Technology's Stimpod NMS460 Non-Invasive Neuromodulation Device for Treatment of Chronic Intractable Pain